Includes bibliographical references and index.
|Statement||S. C. Schimpff, J. Klastersky (eds.).|
|Series||Recent results in cancer research -- 132|
|Contributions||Schimpff, Stephen C., 1941-, Klastersky, Jean.|
|The Physical Object|
|Number of Pages||284|
|ISBN 10||3540564551, 0387564551|
Jointly published in Biol Blood Marrow Transplant 15(10), –; Bone Marrow Transplant 44(8), part 2 Google Scholar 2. Hiemenz JW () Management of infections complicating allogeneic hematopoietic stem cell transplantation. A comparison of these infectious complications with those found in allogeneic bone marrow transplant recipients shows similarities and differences with Cited by: Read 21st Century Ultimate Medical Guide to Bone Marrow Transplantation - Authoritative Clinical. Buy Infectious Complications in Bone Marrow Transplantation (Recent Results in Cancer Research) Softcover reprint of the original 1st ed. by Schimpff, Stephen C. (ISBN: ) from Amazon's Book Store. Everyday low prices and free delivery on eligible : Stephen C. Schimpff.
In 11 patients receiving transplants of allogeneic bone marrow, the graft was successful in six. Nine patients developed infections, and six died—five of septicaemia and one of Pneumocystis carinii pneumonia. Fifty individual infections occurred. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective [published correction appears in Biol Blood Marrow Transplant. 16(2)]. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective Biol Blood Marrow Transplant. Oct;15(10) doi: / Infectious Complications After Allogeneic Hematopoietic Stem Cell Transplantation in Children in a Bone Marrow Transplant Unit in Colombia. Ana Milena Bravo. Universidad del Cauca, Popayán, Colombia. Hospital Universitario San José, Popayán, Colombia. Clínica Nueva, Cali, Colombia.
Hematopoietic stem cell transplantation (HSCT) has been one of the revolutionary discoveries in the world of science leading to cure of many of the hematological malignancies and for several nonmalignant conditions. It involves harvesting of stem cells from either the bone marrow most traditionally, peripheral blood or umbilical cord and then transplanting them into a recipient . INTRODUCTION. Allogeneic bone marrow transplantation (BMT) is the treatment of choice in a great variety of malignant and non-malignant hematologic diseases [1, 2].As only approximately 30% of patients have a matched sibling donor available, volunteer unrelated donor (UD) bone marrow , mobilized peripheral blood  and, more recently, umbilical cord blood  are Cited by: Introduction. Allogeneic bone marrow transplantation (BMT) is the treatment of choice in a great variety of malignant and non‐malignant hematologic diseases [1, 2].As only approximately 30% of patients have a matched sibling donor available, volunteer unrelated donor (UD) bone marrow , mobilized peripheral blood  and, more recently, umbilical cord blood  are becoming increasingly used. Infections during 1-year follow-up in consecutive patients who underwent autologous autologous bone marrow transplantation or peripheral stem cell transplantation for breast cancer. All cases of zoster were limited to 1–2 dermatomes, and the majority occurred within 6 months of by: